China NT Pharma Group Company Limited (HKG:1011)

Hong Kong · Delayed Price · Currency is HKD

0.4100

0.00 (0.00%)

Sep 30, 2026, 9:58 AM HKT

Market Cap	389.09M -46.6%
Revenue (ttm)	41.36M +92.0%
Net Income	-31.83M
EPS	-0.04
Shares Out	949.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Open	0.4100
Previous Close	0.4100
Day's Range	0.4100 - 0.4100
52-Week Range	0.3000 - 1.2000
Beta	-1.99
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 20, 2026

About HKG:1011

China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China. It operates through Agency Services and Healthcare Related Services segments. The company acts as agent for clients to sell proprietary pharmaceutical products and artificial intelligence bone density testings to external customers. It also provides healthcare related research and promotion services in relation to bone health k... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1995

Employees 32

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1011

Full Company Profile

Financial Performance

In 2025, HKG:1011's revenue was 24.16 million, a decrease of -36.36% compared to the previous year's 37.96 million. Losses were -26.04 million, -51.19% less than in 2024.

Financial numbers in CNY Financial Statements